BTC, ETH, SOL, SUI, RENDER, FET, INJ, PEPE | INTRADAY ANALYSIS, TARGETS & KEY LEVELS TO WATCH
2 extracted signals · 0 resolved · 2 still active
KG TRADING - Crypto Elliott WavesIndependent analyst profile- Source published
- 26 Oct 2026, 16:49 UTC
- Recorded by Tahlil Plus
- 26 Oct 2026, 18:43 UTC
AI-generated source summary
The analysis focuses on a bearish outlook for Bitcoin, Ethereum, Solana, and Injective. For BTC, the current price is around 60,352, with a target of 79,227.84 and a failure bound at 55,000. The predicted trend is bearish, though the actual trend is also noted as bearish. For ETH, the current price is 2246.65, targeting 1283.0 with a failure bound at 2480.0, also predicted to be bearish. SOL is trading at 96.38, targeting 75.0 with a failure bound at 116.77, with a bearish prediction. INJ is analyzed with a current price of 6.0094, a target of 4.4771, and a failure bound at 7.3448, also predicted bearish. The overall market sentiment leans bearish across these assets, with specific targets and invalidation levels provided for each, suggesting potential for further downside. The timeframes mentioned or implied are 4-hour for Solana and Injective, and potentially longer for BTC and ETH.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
2 signals remain active.
KG TRADING - Crypto Elliott Waves
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.